Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays revision v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the maintenance notice about government funding status and NIH Clinical Center operating updates from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedThese changes seem to be minor layout and formatting adjustments to the ClinicalTrials.gov page, with no changes to the study title, purpose, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange Detected- Added a government funding notice and operating-status guidance, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check79 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%

- Check93 days agoChange DetectedBump from v3.0.1 to v3.0.2 and removal of the Back to Top link; no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.